These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 20807336)

  • 1. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy.
    Myers RP; Crotty P; Pomier-Layrargues G; Ma M; Urbanski SJ; Elkashab M
    Liver Int; 2010 Nov; 30(10):1471-80. PubMed ID: 20807336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
    Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease.
    Mahadeva S; Mahfudz AS; Vijayanathan A; Goh KL; Kulenthran A; Cheah PL
    J Dig Dis; 2013 Nov; 14(11):604-10. PubMed ID: 23859493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study.
    Myers RP; Elkashab M; Ma M; Crotty P; Pomier-Layrargues G
    Can J Gastroenterol; 2010 Nov; 24(11):661-70. PubMed ID: 21157581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical interpretation of Fibroscan® results: a real challenge.
    Boursier J; Calès P
    Liver Int; 2010 Nov; 30(10):1400-2. PubMed ID: 20849438
    [No Abstract]   [Full Text] [Related]  

  • 8. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.
    Lupsor M; Badea R; Stefanescu H; Grigorescu M; Serban A; Radu C; Crişan D; Sparchez Z; Iancu S; Maniu A
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):53-60. PubMed ID: 20361076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients.
    Kim BK; Han KH; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Kim DY
    Liver Int; 2010 Aug; 30(7):1073-81. PubMed ID: 20492510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
    Behairy Bel-S; Sira MM; Zalata KR; Salama el-SE; Abd-Allah MA
    World J Gastroenterol; 2016 Apr; 22(16):4238-49. PubMed ID: 27122674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
    Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
    J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy.
    Calvaruso V; Cammà C; Di Marco V; Maimone S; Bronte F; Enea M; Dardanoni V; Manousou P; Pleguezuelo M; Xirouchakis E; Attanasio M; Dusheiko G; Burroughs AK; Craxì A
    J Viral Hepat; 2010 Jul; 17(7):469-74. PubMed ID: 19780940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients.
    Wong VW; Lampertico P; de Lédinghen V; Chang PE; Kim SU; Chen Y; Chan HL; Mangia G; Foucher J; Chow WC; Ahn SH; Hou J
    Dig Dis Sci; 2015 May; 60(5):1448-56. PubMed ID: 25563720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease.
    Caussy C; Chen J; Alquiraish MH; Cepin S; Nguyen P; Hernandez C; Yin M; Bettencourt R; Cachay ER; Jayakumar S; Fortney L; Hooker J; Sy E; Valasek MA; Rizo E; Richards L; Brenner DA; Sirlin CB; Ehman RL; Loomba R
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1974-1982.e7. PubMed ID: 29104128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis.
    Ziol M; Kettaneh A; Ganne-Carrié N; Barget N; Tengher-Barna I; Beaugrand M
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1261-8. PubMed ID: 19478678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C.
    Fraquelli M; Rigamonti C; Casazza G; Donato MF; Ronchi G; Conte D; Rumi M; Lampertico P; Colombo M
    J Hepatol; 2011 Apr; 54(4):621-8. PubMed ID: 21146243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
    Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V
    Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.
    Wong VW; Vergniol J; Wong GL; Foucher J; Chan HL; Le Bail B; Choi PC; Kowo M; Chan AW; Merrouche W; Sung JJ; de Lédinghen V
    Hepatology; 2010 Feb; 51(2):454-62. PubMed ID: 20101745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.